摘要: |
[摘要] 目的 观察FOLFOX4方案治疗晚期胃癌的近期疗效和毒副反应。方法 30例晚期胃癌患者,先给予FOLFOX4方案,即:奥沙利铂(L-OHP)85 mg/m2静脉点滴2 h,d1;亚叶酸钙(CF)200 mg/m2静脉点滴2 h,d1、d2,随后5-氟尿嘧啶(5-FU)400 mg/m2静脉推注,d1、d2,5-FU 600 mg/m2微泵持续滴注22 h, d1、d2。2周重复。4个周期后以WHO评价标准评价疗效和毒性。结果 全组30例均可评价,其中完全缓解(CR)2例,部分缓解(PR)16例,稳定(SD)7例,进展(PD)5例,总有效率(CR+PR)60%。中位肿瘤进展时间(TTP)5.5月,中位生存时间(MST)为9个月。毒副反应主要是骨髓抑制,白细胞降低发生率达83.3%,其次为胃肠道反应,恶心呕吐发生率为80.0%,口腔粘膜炎为21.3%,腹泻36.7%,无Ⅳ度胃肠道反应,周围神经毒性发生率为50.0%。结论 FOLFOX4方案治疗晚期胃癌的近期疗效较好,毒副反应可以耐受,值得进一步研究应用。 |
关键词: 晚期胃癌 奥沙利铂 亚叶酸钙 5-氟尿嘧啶 化疗 |
DOI: |
分类号:R 735.2 |
基金项目: |
|
Clinical study of advanced gastric cancer patients treated with leucovorin, 5-fluorouracil and oxaliplatin (FOLFOX4) chemotherapy |
ZHANG Bo
|
Department of Oncology, Guannan People, s Hospital, Guannan 222500, China
|
Abstract: |
[Abstract] Objective To evaluate the efficacy and adverse effects of oxaliplatin combined with 5-fluorouracil(5-FU) and calcium folinate in the treatment of patients with advanced gastric cancer.Methods Thirty patients with advanced gastric cancer received chemotherapy of regimen L-OHP 85 mg/m2 2 hours d1, CF 200 mg/m2 2 hours d1, d2, followed by 5-FU 400 mg/m2 iv and 600 mg/m2 22 hours civ d1, d2, two weeks as one cycle. Efficacy was evaluated after 4 cycles.Results Two patients achieved complete response (CR), 16 patients partial response (PR), 7 patients stable disease (SD), 5 patients progression disease (PD).Total effective rate was 60%. The major toxicity included nausea, vomiting, leucopenia and neurosensory.Conclusion This study shows that the regimen of FOLFOX4 is effective and tolerable in advanced gastric cancer. |
Key words: Advanced gastric cancer Oxaliplatin Calcium folinate 5-Fluorouracil Chemotherapy |